
Trifarma S.p.A. is an international organization manufacturing and supplying APIs to the global pharmaceutical industry.
Our Company boasts a long-lasting tradition in chemistry, started in 1958, during which a steady growth allowed consistent progress in an increasingly regulated and competitive globalized environment.
With a strong focus on excellence, Trifarma aims to offer always the best to its customers, pursuing its guiding values: innovation, teamwork, integrity and respect.
In order to further improve its presence on the globalized pharmaceutical marketplace, the two Italian API factories (formerly named Alchymars SpA and ICM Industria Chimica Milanese SpA) have merged into TRIFARMA SpA, thus creating a larger and industrially, commercially stronger organization.
The Shareholders of Trifarma also control the Indian company Alchymars ICM SM Pvt Ltd (abbreviated as AIS) located in Chennai, India.
1958
Our two italian factories Alchymars and ICM start their manufacture
1980
ICM is global market leader in Phenothiazine manufacturing.
Rozzano site achieves its first US FDA certification
1983
Trifarma starts its business as trading company
1985
Ceriano Laghetto site achieves US FDA certification
1990
Trifarma acquires Alchymars and ICM
2000
Market leader in Clindamycin Phosphate
2001
A new APIs factory in Alathur (Chennai), India starts its operations
2009
Alchymars and ICM are merged into Trifarma S.p.A.
2010
A new manufacturing unit for steroid manufacturing starts operation in our Ceriano Laghetto site
2017
An Italian private equity fund acquires the majority of Trifarma enhancing further growth
2018
First PMDA approval of our Indian manufacturing site
2022
Our Alathur site is now approved by USFDA, PMDA, ANVISA.
2023
Trifarma is selected as CMO partner for a non-pharmaceutical production of innovative products